 |
|
|
| |
Short-Duration Treatment With Sofosbuvir/Velpatasvir Plus GS-9857 in Treatment-Naïve Genotype 1-6 HCV-Infected Patients With or Without Cirrhosis
|
| |
| |
Reported by Jules Levin
EASL 2016 April 14-17 Barcelona
Edward J. Gane,1 Mindie Nguyen,2 Paul Kwo,3 Kris Kowdley,4 Nancy Reau,5 Ira Jacobson,6 Michael Curry,7 Brian Pearlman,8 Omer Khalid,9 Gregory Everson,10 Stuart Gordon,11 John Poulos,12 Aasim Sheikh,13 David Bernstein,14 Jenny C. Yang,15 Luisa M. Stamm,15 Di An,15 Hadas Dvory-Sobol,15 Diana M. Brainard,15 John G. McHutchison,15 Myron Tong,16 Naoky Tsai,17 Kimberly L. Beavers,18 Mordechai Rabinovitz,19 Mitchell Shiffman,20 Catherine Stedman,21 Eric Lawitz22
1Auckland Clinical Studies Ltd, Auckland, New Zealand; 2Stanford University, Stanford, California, USA; 3Indiana University School of Medicine, Indianapolis, Indiana, USA; 4Swedish Medical Center, Seattle, Washington, USA; 5Rush University Medical Center, Chicago, Illinois, USA; 6Mount Sinai Beth Israel, New York, New York, USA; 7Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; 8Atlanta Medical Center, Atlanta, Georgia, USA; 9Digestive Health Specialists, PA, Winston-Salem, North Carolina, USA; 10University of Colorado Anschutz Medical Campus, Aurora, USA; 11Henry Ford Hospital and Health System, Detroit, Michigan, USA; 12Cumberland Research Associates, Fayetteville, North Carolina; 13GI Specialists of Georgia, Marietta; 14Northwell Health, Manhasset, New York; 15Gilead Sciences, Inc., Foster City, California; 16Huntington Medical Research Institutes Liver Center, Pasadena, California; 17Hawaii Medical Center East Liver Center, Honolulu, Hawaii, USA; 18Medical University of South Carolina, Charleston, USA; 19UPMC Center for Liver Diseases, Pittsburgh, Pennsylvania, USA; 20Liver Institute of Virginia, Richmond, USA; 21Christchurch Clinical Studies Trust, Christchurch, New Zealand; 22Texas Liver Institute, San Antonio, Texas, USA
|
| |
|
|
|
|
|
